AVAH vs. AQST
AVAH (Aveanna Healthcare Holdings Inc.) and AQST (Aquestive Therapeutics, Inc.) are both stocks. Both are in the Healthcare sector — AVAH in Medical Care Facilities, AQST in Drug Manufacturers - Specialty & Generic. Over the past 5 years, AVAH returned -1.91%/yr vs 2.60%/yr for AQST. Their 0.18 correlation means their historical movements had little consistent relationship.
Performance
AVAH vs. AQST - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, AVAH achieves a 14.93% return, which is significantly higher than AQST's -42.80% return.
AVAH
- 1D
- -3.10%
- 1M
- 3.19%
- 6M
- 11.79%
- YTD
- 14.93%
- 1Y
- 151.07%
- 3Y*
- 77.47%
- 5Y*
- -1.91%
- 10Y*
- —
- ALL TIME*
- -4.56%
AQST
- 1D
- -0.67%
- 1M
- -11.60%
- 6M
- 25.25%
- YTD
- -42.80%
- 1Y
- -3.27%
- 3Y*
- 18.16%
- 5Y*
- 2.60%
- 10Y*
- —
- ALL TIME*
- -16.07%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $7.65M | $7.26M | $8.26M | |
| $17.44M | $20.18M | $16.91M |
AVAH vs. AQST - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
AVAH Aveanna Healthcare Holdings Inc. | 14.93% | 78.77% | 70.52% | 243.59% | -89.46% | -38.33% |
AQST Aquestive Therapeutics, Inc. | -42.80% | 81.46% | 76.24% | 123.92% | -76.81% | -6.94% |
Correlation
The correlation between AVAH and AQST is 0.08, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.08 |
Correlation (3Y) Balances recent behavior with more history. | 0.19 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.18 |
Correlation (All Time) Calculated using the full available price history since Apr 28, 2021 | 0.18 |
The correlation between AVAH and AQST shifts across timeframes, from 0.08 (1 year) to 0.19 (3 years), reflecting how their relationship changes across market environments.
Fundamentals
AVAH:
$2.04B
AQST:
$463.60M
AVAH:
$1.19
AQST:
-$0.58
AVAH:
0.82
AQST:
8.70
AVAH:
$2.52B
AQST:
$50.27M
AVAH:
$823.98M
AQST:
$20.92M
AVAH:
$306.37M
AQST:
-$53.08M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AVAH vs. AQST — Risk / Return Rank
AVAH
AQST
AVAH vs. AQST - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Aveanna Healthcare Holdings Inc. (AVAH) and Aquestive Therapeutics, Inc. (AQST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| AVAH | AQST | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.10 | ||
| Sortino ratioReturn per unit of downside risk | +2.96 | ||
| Omega ratioGain probability vs. loss probability | 1.43 | 1.09 | +0.35 |
| Calmar ratioReturn relative to maximum drawdown | 3.48 | -0.06 | +3.55 |
| Martin ratioReturn relative to average drawdown | 6.42 | -0.11 | +6.53 |
Loading charts...
Drawdowns
AVAH vs. AQST - Drawdown Comparison
The maximum AVAH drawdown since its inception was -94.76%, roughly equal to the maximum AQST drawdown of -96.68%. Use the drawdown chart below to compare losses from any high point for AVAH and AQST.
Loading charts...
Drawdown Indicators
| AVAH | AQST | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -94.76% | -96.68% | +1.92% |
Max Drawdown (1Y)Largest decline over 1 year | -39.44% | -60.61% | +21.17% |
Max Drawdown (3Y)Largest decline over 3 years | -40.76% | -63.55% | +22.79% |
Max Drawdown (5Y)Largest decline over 5 years | -93.24% | -90.11% | -3.13% |
Current DrawdownCurrent decline from peak | -27.15% | -80.51% | +53.36% |
Average DrawdownAverage peak-to-trough decline | -62.72% | -76.94% | +14.22% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 21.34% | 35.71% | -14.37% |
Volatility
AVAH vs. AQST - Volatility Comparison
Aveanna Healthcare Holdings Inc. (AVAH) and Aquestive Therapeutics, Inc. (AQST) have volatilities of 11.77% and 11.54%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| AVAH | AQST | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.77% | 11.54% | +0.23% |
Volatility (6M)Calculated over the trailing 6-month period | 30.45% | 49.75% | -19.30% |
Volatility (1Y)Calculated over the trailing 1-year period | 66.96% | 84.71% | -17.75% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 78.32% | 82.60% | -4.28% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 76.71% | 87.24% | -10.53% |
Dividends
AVAH vs. AQST - Dividend Comparison
Neither AVAH nor AQST has paid dividends to shareholders.
Financials
AVAH vs. AQST - Financials Comparison
This section allows you to compare key financial metrics between Aveanna Healthcare Holdings Inc. and Aquestive Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
AVAH vs. AQST - Profitability Comparison
AVAH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Aveanna Healthcare Holdings Inc. reported a gross profit of 202.38M and revenue of 647.92M. Therefore, the gross margin over that period was 31.2%.
AQST - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Aquestive Therapeutics, Inc. reported a gross profit of 0.00 and revenue of 14.45M. Therefore, the gross margin over that period was 0.0%.
AVAH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Aveanna Healthcare Holdings Inc. reported an operating income of 75.94M and revenue of 647.92M, resulting in an operating margin of 11.7%.
AQST - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Aquestive Therapeutics, Inc. reported an operating income of -4.20M and revenue of 14.45M, resulting in an operating margin of -29.1%.
AVAH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Aveanna Healthcare Holdings Inc. reported a net income of 41.65M and revenue of 647.92M, resulting in a net margin of 6.4%.
AQST - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Aquestive Therapeutics, Inc. reported a net income of -8.06M and revenue of 14.45M, resulting in a net margin of -55.8%.
Frequently Asked Questions
AVAH and AQST have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AVAH has higher volatility (11.77%) compared to AQST (11.54%). In terms of maximum drawdown, AVAH dropped -94.76% vs AQST's -96.68%.
AVAH currently has the higher Sharpe Ratio (2.05 vs -0.04), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for AVAH and AQST
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer